Cardiology
Conference Coverage
First-trimester blood glucose predicts congenital heart disease risk
NEW ORLEANS – A single random maternal first-trimester plasma glucose level appears to be the strongest predictor of congenital heart disease in...
Conference Coverage
VIDEO: New antisense inhibitor nets impressive reductions in lipids
NEW ORLEANS – A new antisense inhibitor to angiopoietinlike protein 3 (ANGPTL3) reduces lipids in healthy adults with elevated triglyceride levels...
Conference Coverage
Depression further boosts stroke risk in A-fib
NEW ORLEANS – Depression increases stroke risk in patients with atrial fibrillation.
Conference Coverage
VIDEO: ECG screen for cardiac disease in all youths is cost effective
NEW ORLEANS – Adding an ECG to history and physical examination in screening all young people for cardiac disease predisposing to sudden death is...
Conference Coverage
Cardiovascular complications in pregnancy quickly boost future risk
NEW ORLEANS – Women with hypertension in pregnancy or peripartum cardiomyopathy warrant close monitoring thereafter because of their early high...
Conference Coverage
Which maternal beta-blockers boost SGA risk?
NEW ORLEANS – Exposure to labetalol or atenolol during pregnancy is associated with increased risk of having a small-for-gestational-age baby.
Applied Evidence
Atrial fibrillation: Effective strategies using the latest tools
Direct oral anticoagulants or warfarin? Rate or rhythm control? Here’s how to determine which strategies to pursue and when.
Original Research
How in-office and ambulatory BP monitoring compare: A systematic review and meta-analysis
Isolated office BP measurement is insufficient to confirm or rule out poorly controlled hypertension, and it increases the likelihood of under- or...
Audio
Statins in adults with CVD risk: The latest from the USPSTF
Find out how the most recent recommendations from the USPSTF differ from those of the American College of Cardiology/American Heart Association...
Guidelines
ADA: Empagliflozin and liraglutide reduce type 2 CV death
Empagliflozin (Jardiance) and liraglutide (Victoza) should be considered in type 2 diabetes patients with documented cardiovascular disease to...
Conference Coverage
Options narrow for acute decompensated heart failure
Acute decompensated heart failure is a condition that clinicians want to prevent rather than treat.